drugset / Trial / NCT01773967

Summary

The investigators will study the efficacy and side effect profile of LGG, a probiotic, in pediatric patients with acute gastroenteritis.

Timeline

Start
2014-07
Primary completion
2018-08
Completion
2018-08

Outcome

Missed primary endpoint

registry analysis (superiority test); Lactobacillus rhamnosus GG vs Placebo; p = 0.83; Mantel Haenszel NCT01773967 ↗

paper L. rhamnosus GG did not have better outcomes than those who received placebo. PMID 30462938 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactobacillus rhamnosus GG Other / unclassified 1e+10 cells Oral

Indications